) business unit - SAFC Commercial ("SAFC") - and
Applied Genetic Technologies Corporation
) have inked a deal, under which, SAFC will provide gene therapy
manufacturing services to companies developing gene-based
therapies. The companies did not disclose the financial terms of
AGTC's proprietary HAVE system enables the manufacturing of
adeno-associated virus (AAV) vectors, which strategically fits into
SAFC's portfolio of services and is also consistent with its
quality and technical capabilities. Under the deal terms, the
companies will jointly market HAVE manufacturing method with SAFC's
cGMP manufacturing capabilities.
AAV vectors have a wide scope in treating a variety of genetic
diseases but it was difficult to develop them in a cost efficient
manner at clinics and commercially. However, ACTG's proprietary
HAVE system has made it happen. By partnering with SAFC, AGTC will
be able to make its AAV manufacturing platform available to
academic and corporate organizations that pursue gene-based
SAFC has a considerable proficiency with AGTC's HAVE system and
also delivers a high level of service to its contract manufacturing
customers. SAFC will provide the customers with high-quality and
timely cGMP manufacturing services.
Through this partnership, clients will also have access to
bio-manufacturing testing services from BioReliance, which is the
biologics and early-development services business of SAFC.
Revenues from SAFC Commercial - Sigma-Aldrich's custom
manufacturing services business unit - went up 3% to $159 million
in first-quarter 2014. Sales rose in the low single-digits
organically in life science products business while life science
services saw a double-digit rise on gains in biopharma services.
However, SAFC Hitech sales declined in the low single-digits due to
Sigma-Aldrich's significant investments in sales, marketing and
R&D initiatives are generating demand for its products. The
company tries to take advantage of country-specific opportunities
by expanding its presence in high-growth emerging markets. It is
actively expanding its foothold in the Asia-Pacific region,
especially in the fast-growing emerging markets of India and China.
Sigma-Aldrich currently carries a Zacks Rank #4 (Sell).
Other companies in the specialty chemical space with favorable
Zacks Rank include
Minerals technologies Inc.
International Flavors & Fragrances Inc.
). While Minerals technologies carries a Zacks Rank #1 (Strong
Buy), International Flavors & Fragrances holds a Zacks Rank #2
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
SIGMA ALDRICH (SIAL): Free Stock Analysis
INTL F & F (IFF): Free Stock Analysis
MINERAL TECH (MTX): Free Stock Analysis Report
APPLIED GEN TEC (AGTC): Free Stock Analysis
To read this article on Zacks.com click here.